A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2000 ◽
Vol 111
(1)
◽
pp. 381-381
◽
2020 ◽
Keyword(s):
2017 ◽
Vol 4
(10)
◽